CTXR Annual Short Term Debt
$241.50 K
+$23.10 K+10.58%
30 September 2024
Summary:
As of January 23, 2025, CTXR annual short term debt is $241.50 thousand, with the most recent change of +$23.10 thousand (+10.58%) on September 30, 2024. During the last 3 years, it has risen by +$64.30 thousand (+36.29%). CTXR annual short term debt is now -64.12% below its all-time high of $673.00 thousand, reached on September 30, 2016.CTXR Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CTXR Quarterly Short Term Debt
$241.50 K
+$5900.00+2.50%
30 September 2024
Summary:
As of January 23, 2025, CTXR quarterly short term debt is $241.50 thousand, with the most recent change of +$5900.00 (+2.50%) on September 30, 2024. Over the past year, it has increased by +$5900.00 (+2.50%). CTXR quarterly short term debt is now -95.54% below its all-time high of $5.42 million, reached on June 30, 2017.CTXR Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CTXR Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10.6% | +2.5% |
| 3 y3 years | +36.3% | +2.5% |
| 5 y5 years | +39.6% | +2.5% |
CTXR Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +36.3% | at high | +32.7% |
| 5 y | 5-year | -27.3% | +39.6% | -29.2% | +36.3% |
| alltime | all time | -64.1% | -95.5% |
Citius Pharmaceuticals Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | $241.50 K(+10.6%) | $241.50 K(+2.5%) |
| June 2024 | - | $235.60 K(+2.6%) |
| Mar 2024 | - | $229.70 K(+2.5%) |
| Dec 2023 | - | $224.00 K(+2.6%) |
| Sept 2023 | $218.40 K(+10.9%) | $218.40 K(+2.6%) |
| June 2023 | - | $212.90 K(+2.6%) |
| Mar 2023 | - | $207.50 K(+2.6%) |
| Dec 2022 | - | $202.20 K(+2.6%) |
| Sept 2022 | - | $197.00 K(+2.7%) |
| Sept 2022 | $197.00 K(+11.2%) | - |
| June 2022 | - | $191.90 K(+2.7%) |
| Mar 2022 | - | $186.90 K(+2.7%) |
| Dec 2021 | - | $182.00 K(+2.7%) |
| Sept 2021 | $177.20 K(-46.6%) | $177.20 K(-47.4%) |
| June 2021 | - | $337.10 K(-1.1%) |
| Mar 2021 | - | $340.90 K(+1.3%) |
| Dec 2020 | - | $336.40 K(+1.3%) |
| Sept 2020 | $332.00 K(+91.9%) | $332.00 K(+1.3%) |
| June 2020 | - | $327.60 K(+1.3%) |
| Mar 2020 | - | $323.40 K(+1.3%) |
| Dec 2019 | - | $319.20 K(+84.5%) |
| Sept 2019 | $173.00 K(0.0%) | $173.00 K(0.0%) |
| June 2019 | - | $173.00 K(0.0%) |
| Mar 2019 | - | $173.00 K(0.0%) |
| Dec 2018 | - | $173.00 K(0.0%) |
| Sept 2018 | $173.00 K | $173.00 K(0.0%) |
| June 2018 | - | $173.00 K(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $173.00 K(0.0%) |
| Dec 2017 | - | $173.00 K(0.0%) |
| Sept 2017 | $173.00 K(-74.3%) | $173.00 K(-96.8%) |
| June 2017 | - | $5.42 M(+167.7%) |
| Mar 2017 | - | $2.02 M(+35.5%) |
| Dec 2016 | - | $1.49 M(+121.8%) |
| Sept 2016 | $673.00 K(>+9900.0%) | $673.00 K(+289.0%) |
| June 2016 | - | $173.00 K(-77.6%) |
| Mar 2016 | - | $773.00 K(>+9900.0%) |
| Sept 2015 | $0.00(-100.0%) | $0.00(0.0%) |
| June 2015 | - | $0.00(0.0%) |
| Mar 2015 | - | $0.00(0.0%) |
| Dec 2014 | - | $0.00(-100.0%) |
| Sept 2014 | $600.00 K(>+9900.0%) | $600.00 K(+1954.8%) |
| June 2014 | - | $29.20 K(+20.7%) |
| Mar 2014 | - | $24.20 K(+16.9%) |
| Dec 2013 | - | $20.70 K(+546.9%) |
| Sept 2013 | $3200.00(-91.7%) | $3200.00(-93.8%) |
| June 2013 | - | $51.80 K(+6.6%) |
| Mar 2013 | - | $48.60 K(+24.9%) |
| Dec 2012 | - | $38.90 K(+0.5%) |
| Sept 2012 | $38.70 K(>+9900.0%) | $38.70 K(+16.2%) |
| June 2012 | - | $33.30 K(+22.4%) |
| Mar 2012 | - | $27.20 K(+31.4%) |
| Dec 2011 | - | $20.70 K(>+9900.0%) |
| Sept 2011 | $0.00 | $0.00(-100.0%) |
| June 2011 | - | $13.40 K |
FAQ
- What is Citius Pharmaceuticals annual short term debt?
- What is the all time high annual short term debt for Citius Pharmaceuticals?
- What is Citius Pharmaceuticals annual short term debt year-on-year change?
- What is Citius Pharmaceuticals quarterly short term debt?
- What is the all time high quarterly short term debt for Citius Pharmaceuticals?
- What is Citius Pharmaceuticals quarterly short term debt year-on-year change?
What is Citius Pharmaceuticals annual short term debt?
The current annual short term debt of CTXR is $241.50 K
What is the all time high annual short term debt for Citius Pharmaceuticals?
Citius Pharmaceuticals all-time high annual short term debt is $673.00 K
What is Citius Pharmaceuticals annual short term debt year-on-year change?
Over the past year, CTXR annual short term debt has changed by +$23.10 K (+10.58%)
What is Citius Pharmaceuticals quarterly short term debt?
The current quarterly short term debt of CTXR is $241.50 K
What is the all time high quarterly short term debt for Citius Pharmaceuticals?
Citius Pharmaceuticals all-time high quarterly short term debt is $5.42 M
What is Citius Pharmaceuticals quarterly short term debt year-on-year change?
Over the past year, CTXR quarterly short term debt has changed by +$5900.00 (+2.50%)